We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

92 hedge funds and large institutions have $1.08B invested in Sage Therapeutics in 2015 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

158% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 12

133% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 15

47% more capital invested

Capital invested by funds: $735M → $1.08B (+$345M)

26% more funds holding

Funds holding: 73 → 92 (+19)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
92
Holders Change
+19
Holders Change %
+26.03%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
31
Increased
35
Reduced
15
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$26.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$17.2M
3
Franklin Resources
Franklin Resources
California
+$16.7M
4
ORI
Oak Ridge Investments
Illinois
+$16.6M
5
DM
Deerfield Management
New York
+$14.3M

Top Sellers

Rank Fund Capital Flow
1
TRV
Third Rock Ventures
Massachusetts
-$82M
2
EC
EcoR1 Capital
California
-$16.3M
3
FCMI
Foresite Capital Management II
California
-$5.29M
4
NI
Numeric Investors
Massachusetts
-$1.79M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$3.77M – – –
State Street
27
State Street
Massachusetts
$3.76M +$89.1K +2,072 +3%
PCM
28
Palisade Capital Management
New Jersey
$3.66M +$3.13M +72,797 New
BIT
29
BlackRock Institutional Trust
California
$3.65M +$747K +17,380 +31%
PA
30
Perceptive Advisors
New York
$3.54M – – –
SFM
31
Sphera Funds Management
Israel
$3.3M -$602K -14,000 -18%
Northern Trust
32
Northern Trust
Illinois
$3.09M +$128K +2,979 +5%
DIA
33
Denver Investment Advisors
Colorado
$3.07M +$1.24M +28,940 +90%
NIP
34
Nicholas Investment Partners
California
$2.83M -$384K -8,940 -14%
UBS AM
35
UBS AM
Illinois
$2.42M -$51.6K -1,200 -2%
NLVP
36
New Leaf Venture Partners
New York
$2.2M +$361K +8,400 +24%
EAM
37
Eventide Asset Management
Massachusetts
$2.02M – – –
Geode Capital Management
38
Geode Capital Management
Massachusetts
$1.9M +$126K +2,942 +8%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.89M -$82.6K -1,921 -5%
TI
40
Trexquant Investment
Connecticut
$1.3M +$1.11M +25,815 New
TC
41
TFS Capital
Pennsylvania
$1.26M +$1.08M +25,069 New
NFA
42
Nationwide Fund Advisors
Ohio
$1.26M +$38.8K +903 +4%
VAM
43
Visium Asset Management
New York
$1.26M +$1.07M +25,000 New
Deutsche Bank
44
Deutsche Bank
Germany
$1.11M +$404K +9,395 +74%
ProShare Advisors
45
ProShare Advisors
Maryland
$1.09M +$148K +3,444 +19%
CS
46
Credit Suisse
Switzerland
$1.04M +$443K +10,299 +98%
BIM
47
BlackRock Investment Management
Delaware
$960K +$19.2K +447 +2%
USAA
48
United Services Automobile Association
Texas
$877K +$750K +17,456 New
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$844K – – –
TAM
50
Tocqueville Asset Management
New York
$823K +$704K +16,375 New
1
2
3 4 5

SAGE Hedge Fund Activity: Q1 2015 in Review

92 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q1 2015, worth a combined $1.08B — up 47% from $735M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SAGE positions and 12 closed out — a net gain of 19 holders — while 35 added to existing stakes and 15 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $26.5M. The largest seller was Third Rock Ventures, cutting an estimated $82M.

  • 92 institutional investors held Sage Therapeutics (SAGE) as of Q1 2015, up from 73 in Q4 2014.
  • Funds reported $1.08B of Sage Therapeutics stock for Q1 2015, up 47% quarter-over-quarter.
  • 31 funds opened new Sage Therapeutics positions in Q1 2015 and 12 closed out, a net change of +19 holders.
  • The largest Sage Therapeutics buyer in Q1 2015 was JP Morgan Chase, an estimated $26.5M added.
  • The largest Sage Therapeutics seller in Q1 2015 was Third Rock Ventures, an estimated $82M sold.

Based on aggregated 13F filings for Q1 2015.